Quantum-Si incorporated
General ticker "QSI" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $255.5M (TTM average)
Quantum-Si incorporated does not follow the US Stock Market performance with the rate: -0.4%.
Estimated limits based on current volatility of 4.2%: low 1.17$, high 1.27$
Factors to consider:
- Total employees count: 143 (-13.3%) as of 2024
- US accounted for 39.2% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Limited operating history, Commercialization challenges, Sales and marketing challenges, Geopolitical risks, Regulatory and compliance
- Price in estimated range
- Earnings for 3 months up through Q1 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.85$, 2.14$]
- 2026-12-31 to 2027-12-31 estimated range: [0.92$, 2.26$]
Financial Metrics affecting the QSI estimates:
- Positive: with PPE of -2.3 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Negative: negative Net income
- Positive: Shareholder equity ratio, % of 89.67 > 64.29
- Positive: Inventory ratio change, % of -0.33 <= 0
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term QSI quotes
Long-term QSI plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1.08MM | $3.06MM | $2.44MM |
| Operating Expenses | $112.25MM | $111.63MM | $99.80MM |
| Operating Income | $-111.17MM | $-108.58MM | $-97.36MM |
| Non-Operating Income | $15.21MM | $7.62MM | $-3.92MM |
| R&D Expense | $67.03MM | $59.64MM | $53.76MM |
| Income(Loss) | $-95.96MM | $-100.95MM | $-101.28MM |
| Taxes | $0.00MM | $0.06MM | $0.06MM |
| Net Income(Loss)* | $-95.96MM | $-101.01MM | $-101.34MM |
| Stockholders Equity | $271.62MM | $215.42MM | $220.23MM |
| Inventory | $3.94MM | $4.07MM | $3.20MM |
| Assets | $298.25MM | $247.87MM | $245.61MM |
| Operating Cash Flow | $-94.04MM | $-87.80MM | $-94.72MM |
| Capital expenditure | $5.27MM | $4.58MM | $2.52MM |
| Investing Cash Flow | $143.43MM | $-32.67MM | $-28.32MM |
| Financing Cash Flow | $0.15MM | $35.88MM | $95.42MM |
| Earnings Per Share** | $-0.68 | $-0.71 | $-0.51 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.